Government proposes simplifying procedure for import of drugs for examination, test, or analysis under Drugs Rules, 1945
The Indian Health Ministry has proposed simplifying the import process for drugs intended for testing and R&D by replacing licensing with an acknowledgement-based system. This move aims to reduce compliance burdens for pharmaceutical companies and startups.
Why it matters
Deregulation in the pharmaceutical R&D sector is expected to accelerate innovation and speed up the testing of new medical products.
Union Health Ministry has proposed amendments to the Drugs Rules, 1945 to simplify the procedure for obtaining permission for import of drugs for examination, test or analysis. The amendment introduces an acknowledgement-based system for import of all drugs in small quantities for analytical and non-clinical testing purposes.
The article objectively outlines government policy changes and their intended economic benefits.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in